Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 972 JPY 0.21%
Market Cap: 27.3B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Other Long-Term Assets
ÂĄ1.5B
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
33%
GNI Group Ltd
TSE:2160
Other Long-Term Assets
ÂĄ258m
CAGR 3-Years
27%
CAGR 5-Years
-8%
CAGR 10-Years
42%
PeptiDream Inc
TSE:4587
Other Long-Term Assets
ÂĄ4.8B
CAGR 3-Years
116%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Other Long-Term Assets
ÂĄ2.4B
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
7%
S
StemRIM Inc
TSE:4599
Other Long-Term Assets
ÂĄ14.6m
CAGR 3-Years
-45%
CAGR 5-Years
14%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Other Long-Term Assets
ÂĄ41.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
27.3B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 540.04 JPY
Undervaluation 62%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
1.5B JPY

Based on the financial report for Jul 31, 2024, Pharma Foods International Co Ltd's Other Long-Term Assets amounts to 1.5B JPY.

What is Pharma Foods International Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
33%

Over the last year, the Other Long-Term Assets growth was -5%. The average annual Other Long-Term Assets growth rates for Pharma Foods International Co Ltd have been 31% over the past three years , 28% over the past five years , and 33% over the past ten years .

Back to Top